Clinical outcome analysis of two approaches to trypan blue dyeing for DMEK.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 Jul 2024
Historique:
received: 22 03 2024
accepted: 15 07 2024
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 19 7 2024
Statut: epublish

Résumé

To evaluate the clinical implications of the different trypan blue dyeing techniques used during liquid bubble (LBT) and manual peel (MPT) DMEK lenticule preparation techniques. This study retrospectively compared the degree to which endothelial cells are preserved using selective Descemet Membrane (DM) staining (LBT) versus bath-staining (MPT) when performed by a single surgeon, sourced from a single eye bank. Endothelial cell density measured after the 3-month follow-up was 1805 and 1916 cells/mm

Identifiants

pubmed: 39030334
doi: 10.1038/s41598-024-67695-2
pii: 10.1038/s41598-024-67695-2
doi:

Substances chimiques

Trypan Blue I2ZWO3LS3M
Coloring Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16663

Informations de copyright

© 2024. The Author(s).

Références

Sabater-Cruz, N., Figueras-Roca, M., Padró-Pitarch, L., Tort, J. & Casaroli-Marano, R. P. Corneal transplantation activity in Catalonia, Spain, from 2011 to 2018: Evolution of indications and surgical techniques. PLoS ONE 16(4), e0249946 (2021).
doi: 10.1371/journal.pone.0249946 pubmed: 33831081 pmcid: 8031423
Galvis, V. et al. Corneal transplantation at an ophthalmological referral center in Colombia: indications and techniques (2004–2011). Open Ophthalmol. J. 7, 30–33 (2013).
doi: 10.2174/1874364101307010030 pubmed: 23898357 pmcid: 3722533
Rezaei Kanavi, M. et al. Trends in Indications and Techniques of Corneal Transplantation in Iran from 2006 to 2013; An 8-year Review. J. Ophthalmic Vis. Res. 11(2), 146–152 (2016).
doi: 10.4103/2008-322X.183930 pubmed: 27413493 pmcid: 4926560
Dunker, S. L. et al. Real-World Outcomes of DMEK: A Prospective Dutch registry study. Am. J. Ophthalmol. 222, 218–225 (2021).
doi: 10.1016/j.ajo.2020.06.023 pubmed: 32621899
Dapena, I., Ham, L. & Melles, G. R. J. Endothelial keratoplasty: DSEK/DSAEK or DMEK–the thinner the better?. Curr. Opin. Ophthalmol. 20(4), 299–307 (2009).
doi: 10.1097/ICU.0b013e32832b8d18 pubmed: 19417653
Marques, R. E. et al. DMEK versus DSAEK for Fuchs’ endothelial dystrophy: A meta-analysis. Eur J Ophthalmol. 29(1), 15–22 (2019).
doi: 10.1177/1120672118757431 pubmed: 29661044
Weisenthal, R. W., Yin, H. Y., Jarstad, A. R., Wang, D. & Verdier, D. D. Long-term Outcomes in Fellow Eyes Comparing DSAEK and DMEK for Treatment of Fuchs Corneal Dystrophy. Am. J. Ophthalmol. 233, 216–226 (2022).
doi: 10.1016/j.ajo.2021.06.013 pubmed: 34157279
Romano, V. et al. Clinical outcomes of pre-loaded ultra-thin DSAEK and pre-loaded DMEK. BMJ open Ophthalmol. 5(1), e000546 (2020).
doi: 10.1136/bmjophth-2020-000546 pubmed: 33094167 pmcid: 7569929
Singh R, Gupta N, Vanathi M, Tandon R. Corneal transplantation in the modern era. Indian J Med Res, https://pubmed.ncbi.nlm.nih.gov/31571625 , (2019).
Liu, S. & Veldman, P. Evidence-based endothelial rehabilitation. Semin Ophthalmol. 32(1), 96–103 (2017).
doi: 10.1080/08820538.2016.1228409 pubmed: 27754721
van Dijk, K. et al. Near complete visual recovery and refractive stability in modern corneal transplantation: Descemet membrane endothelial keratoplasty (DMEK). Cont Lens Anterior Eye 36(1), 13–21 (2013).
doi: 10.1016/j.clae.2012.10.066 pubmed: 23108011
Price, M. O., Giebel, A. W., Fairchild, K. M. & Price, F. W. J. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology 116(12), 2361–2368 (2009).
doi: 10.1016/j.ophtha.2009.07.010 pubmed: 19875170
Maier, A.-K.B. et al. Fellow Eye Comparison of Descemet Membrane Endothelial Keratoplasty and Penetrating Keratoplasty. Cornea 32(10), 1344–1348 (2013).
doi: 10.1097/ICO.0b013e31829dd816 pubmed: 23928950
Hahn, D. & Davies, E. Descemet's membrane endothelial keratoplasty tissue type and endothelial cell loss over time. Can J Ophthalmol. 58(3), 187–190. https://doi.org/10.1016/j.jcjo.2021.11.007 (2023).
Inoda, S. et al. Risk Factors for Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty. Cornea 38(7), 820–824 (2019).
doi: 10.1097/ICO.0000000000001950 pubmed: 30973407 pmcid: 6571176
Yoeruek, E., Bayyoud, T., Hofmann, J., Szurman, P. & Bartz-Schmidt, K.-U. Comparison of pneumatic dissection and forceps dissection in Descemet membrane endothelial keratoplasty: histological and ultrastructural findings. Cornea. 31(8), 920–925 (2012).
doi: 10.1097/ICO.0b013e31823f7870 pubmed: 22511023
Tenkman, L. R., Price, F. W. & Price, M. O. Descemet membrane endothelial keratoplasty donor preparation: Navigating challenges and improving efficiency. Cornea 33(3), 319–325 (2014).
doi: 10.1097/ICO.0000000000000045 pubmed: 24452215
Fuchsluger, T. A., Kruse, F. E. & Geerling, G. Endothelkritische Prozeduren während der Herstellung und Transplantation posteriorer lamellärer Hornhauttransplantate. Der. Ophthalmol. 114(8), 688–692. https://doi.org/10.1007/s00347-017-0524-9 (2017).
doi: 10.1007/s00347-017-0524-9
Armitage, W. J., Dick, A. D. & Bourne, W. M. Predicting Endothelial Cell Loss and Long-Term Corneal Graft Survival. Invest. Ophthalmol. Vis. Sci. 44(8), 3326–3331. https://doi.org/10.1167/iovs.02-1255 (2003).
doi: 10.1167/iovs.02-1255 pubmed: 12882777
Kruse FE, Schrehardt US, Tourtas T. Optimizing outcomes with Descemet’s membrane endothelial keratoplasty. Curr. Opin Ophthalmol. https://journals.lww.com/co-ophthalmology/Fulltext/2014/07000/Optimizing_outcomes_with_Descemet_s_membrane.16.aspx , (2014).
Muraine, M. et al. Novel technique for the preparation of corneal grafts for descemet membrane endothelial keratoplasty. Am. J. Ophthalmol. 156(5), 851–859 (2013).
doi: 10.1016/j.ajo.2013.05.041 pubmed: 23932263
Rickmann, A. et al. Clinical Comparison of Two Methods of Graft Preparation in Descemet Membrane Endothelial Keratoplasty. Curr. Eye Res. 43(1), 12–17 (2018).
doi: 10.1080/02713683.2017.1368086 pubmed: 28937824
Parekh, M. et al. Descemet membrane endothelial keratoplasty tissue preparation from donor corneas using a standardized submerged hydro-separation method. Am. J. Ophthalmol. 158(2), 277-285.e1 (2014).
doi: 10.1016/j.ajo.2014.04.009 pubmed: 24792104
Solley, K. D. et al. DescePrep Significantly Increases Descemet Membrane Endothelial Keratoplasty Processing Efficiency and Success Rate in Diabetic Human Donor Corneas in Comparison With Manual Dissection. Cornea 41(10), 1284–1290 (2022).
doi: 10.1097/ICO.0000000000003096 pubmed: 35867682
Szurman, P. et al. Novel liquid bubble dissection technique for DMEK lenticule preparation. Graefe’s Arch. Clin. Exp. Ophthalmol. 254(9), 1819–1823 (2016).
doi: 10.1007/s00417-016-3377-z
Thaler, S. et al. Methyl blue and aniline blue versus patent blue and trypan blue as vital dyes in cataract surgery: Capsule staining properties and cytotoxicity to human cultured corneal endothelial cells. J. Cataract Refract Surg. 37(6), 1147–1153 (2011).
doi: 10.1016/j.jcrs.2010.12.051 pubmed: 21596258
Guerra, F. P., Anshu, A., Price, M. O., Giebel, A. W. & Price, F. W. Descemet’s membrane endothelial keratoplasty: Prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology 118(12), 2368–2373 (2011).
doi: 10.1016/j.ophtha.2011.06.002 pubmed: 21872938
Schlögl, A., Tourtas, T., Kruse, F. E. & Weller, J. M. Long-term Clinical Outcome After Descemet Membrane Endothelial Keratoplasty. Am. J. Ophthalmol. 169, 218–226 (2016).
doi: 10.1016/j.ajo.2016.07.002 pubmed: 27423793
Dua, H. S., Katamish, T., Said, D. G. & Faraj, L. A. Differentiating type 1 from type 2 big bubbles in deep anterior lamellar keratoplasty. Clin. Ophthalmol. 26(9), 1155–1157 (2015).
doi: 10.2147/OPTH.S81089
Trouvain, A. M., Szurman, P., Bocqué, C. & Rickmann, A. Liquid bubble dissection technique assures rapid and safe DMEK lamella preparation. Graefe’s Arch. Clin. Exp. Ophthalmol. 259, 3519–3520 (2021).
doi: 10.1007/s00417-021-05299-6
Oellerich, S. et al. Parameters Associated With Endothelial Cell Density Variability After Descemet Membrane Endothelial Keratoplasty. Am. J. Ophthalmol. 211, 22–30 (2020).
doi: 10.1016/j.ajo.2019.10.017 pubmed: 31647928
Price, M. O., Kanapka, L., Kollman, C., Lass, J. H. & Price, F. W. J. Descemet Membrane Endothelial Keratoplasty: 10-Year Cell Loss and Failure Rate Compared With Descemet Stripping Endothelial Keratoplasty and Penetrating Keratoplasty. Cornea https://doi.org/10.1097/ICO.0000000000003446 (2023).
doi: 10.1097/ICO.0000000000003446 pubmed: 38128100 pmcid: 10836783
Shahnazaryan, D., Hajjar Sese, A. & Hollick, E. J. Endothelial Cell Loss After Descemet’s Membrane Endothelial Keratoplasty for Fuchs’ Endothelial Dystrophy: DMEK Compared to Triple DMEK. Am. J. Ophthalmol. 218, 1–6 (2020).
doi: 10.1016/j.ajo.2020.05.003 pubmed: 32437670
Droutsas, K. et al. Comparison of endothelial cell loss and complications following DMEK with the use of three different graft injectors. Eye 32(1), 19–25 (2018).
doi: 10.1038/eye.2017.237 pubmed: 29148524
Parekh, M. et al. A comparative study on different Descemet membrane endothelial keratoplasty graft preparation techniques. Acta Ophthalmol. 96(6), e718–e726 (2018).
doi: 10.1111/aos.13746 pubmed: 29520992
Bhogal, M., Balda, M. S., Matter, K. & Allan, B. D. Global cell-by-cell evaluation of endothelial viability after two methods of graft preparation in Descemet membrane endothelial keratoplasty. Br. J. Ophthalmol. 100(4), 572–578 (2016).
doi: 10.1136/bjophthalmol-2015-307534 pubmed: 26740609
Van Dooren, B. T. H., Beekhuis, W. H. & Pels, E. Biocompatibility of trypan blue with human corneal cells. Arch. Ophthalmol. 122(5), 736–742 (2004).
doi: 10.1001/archopht.122.5.736 pubmed: 15136322
Nagashima, T., Yuda, K. & Hayashi, T. Comparison of trypan blue and Brilliant Blue G for staining of the anterior lens capsule during cataract surgery: short-term results. Int. Ophthalmol. 39(1), 33–39 (2019).
doi: 10.1007/s10792-017-0779-9 pubmed: 29188471
Weber, I. P. et al. Effect of vital dyes on human corneal endothelium and elasticity of Descemet’s membrane. PLoS One 12(9), e0184375 (2017).
doi: 10.1371/journal.pone.0184375 pubmed: 28902856 pmcid: 5597301
Straiko, M. M. W., Odell, K., Blitzer, A. L., Tran, K. D. & Veldman, P. B. Double-Scroll Formation by Fluid Column Manipulation in Preloaded DMEK Grafts Prepared From Younger and Older Donor Tissue. Cornea 42(3), 351–358 (2023).
doi: 10.1097/ICO.0000000000003135 pubmed: 36255778
Odell, K. et al. Examination of a Modified Graft Preparation Technique to Induce Double-Scroll Formation and Promote the Use of Younger Descemet Membrane Endothelial Keratoplasty Donor Tissue. Cornea 41(10), 1276–1283 (2022).
doi: 10.1097/ICO.0000000000003083 pubmed: 36107846
Siebelmann, S. et al. The Cologne rebubbling study: a reappraisal of 624 rebubblings after Descemet membrane endothelial keratoplasty. Br. J. Ophthalmol. 105(8), 1082–1086 (2021).
doi: 10.1136/bjophthalmol-2020-316478 pubmed: 32816807
Gundlach, E. et al. Impact of Re-bubbling after Descemet Membrane Endothelial Keratoplasty on Long-term Results. Curr. Eye Res. 46(6), 784–788 (2021).
doi: 10.1080/02713683.2020.1842459 pubmed: 33179517
Straiko, M. D. et al. Donor DMEK Tissue Characteristics: Association With Rebubble Rate and 6-Month Endothelial Cell Loss. Cornea 39(10), 1267–1273 (2020).
doi: 10.1097/ICO.0000000000002398 pubmed: 32558729
Tapley, J. L. et al. Rate of Endothelial Cell Loss and Graft Survival in Descemet Membrane Endothelial Keratoplasty in Eyes Requiring a Rebubble. Cornea 42(8), 934–939 (2023).
doi: 10.1097/ICO.0000000000003118 pubmed: 36731078

Auteurs

Ruth Donner (R)

Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. ruth.donner@meduniwien.ac.at.

Gerald Schmidinger (G)

Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH